...
....
Pharmaceutical
Biotechnology

> See specialized channels
Medical Devices & Diagnostics
> See specialized channels
Industrial
Biotechnology
> See specialized channels


  Join us

  Follow us on Twitter   Join our LinkedIn Group   Our Blog

Biotech News App
Provides access to the latest biotech press releases ...more

Android_Logo App Store RIM_Logo_small

Media Partnership:
Want to have your RSS feed integrated on our website? Contact us
RSS Feeds RSS Feeds
JoomlaWatch Stats 1.2.9 by Matej Koval
For Editors
Sign up for press releases
For Companies
Sign up for our newsletter


All Biotech Press Releases



> Evercyte and VTU Technology Collaborate On Development of Recombinant Media Supplements
05/24/16
> ProBioGen Will License GlymaxX® to Thermo Fisher Scientific for Use in Developing Allergy Diagnostics
05/18/16
> Ganymed to Present Exciting Phase II Clinical Data for IMAB362 in Gastroesophageal Cancer at ASCO 2016 Annual Meeting
05/17/16
> Vetter is a Winner of the AbbVie TRIUMPH AWARD
05/11/16
> LDC and Boehringer Ingelheim Join Forces to Discover a Novel Approach for the Treatment of Schizophrenia
05/11/16
> EMA/CHMP Adopts Positive Opinion for ITM´s EndolucinBeta®
05/10/16
> RedHill Biopharma Announces National Cancer Institute Grant Supporting YELIVA™ Phase II Hepatocellular Carcinoma Study
05/05/16
> Isarna Presents First Interim Phase I Data for ISTH0036 in Advanced Glaucoma at ARVO 2016 Annual Conference
05/04/16
> Orchard Therapeutics Launches and Announces Academic Partnerships for Development of Transformative Gene Therapies
05/03/16
> CyTuVax Reports Interim Results of the Phase I Clinical Trial with the HBAI20 Hepatitis B Vaccine for Non-Responders
04/29/16
> Cristal Therapeutics Announces Appointment of Edwin Klumper as Chief Medical Officer
04/29/16
> VTU Technology and Boehringer Ingelheim Strengthen Their Global Microbial Technology Collaboration
04/27/16
> ProBioGen and Eucodis Sign Agreement to Commercialize C-LiNK, a Novel Antibody Drug Conjugation Technology
04/19/16
> Agendia’s MammaPrint® First and Only Genomic Assay to Receive Level 1A Clinical Utility Evidence for Chemotherapy Benefit in Early Breast Cancer Patients
04/19/16
> RedHill Biopharma Announces Positive FDA Meeting on RHB-105 Path to Approval and Planned Confirmatory Phase III Study for H. pylori Infection
04/18/16
> Selvita Files IND Application for its Novel, Dual PIM/FLT3 Inhibitor in AML
04/18/16
> MINDACT Trial Findings on Agendia’s MammaPrint to be Presented during AACR Annual Meeting 2016
04/15/16
> Apollo Therapeutics: Dr Richard Butt Appointed CEO
04/14/16
> Tech Transfer: 9th BioVaria to Take Place in Munich on 17 May 2016
04/13/16
> Susanne Resatz, President of Vetter Development Services USA, Inc. is Elected to the Board of Directors of the German American Chamber of Commerce® of the Midwest, Inc.
04/12/16
> RedHill Biopharma Initiates Phase II Study of BEKINDA™ for Irritable Bowel Syndrome
04/12/16
> Forbion Closes Third Life Sciences Fund, FCF III, Raising over USD200M
04/12/16
> 4th Laupheim Biotech Days to Take Place June 13 to 14, 2016
04/11/16
> Adherium Appoints Senior Executive to Lead Market Expansion and Establishes European Operations
04/04/16
> RedHill Biopharma Announces Interim Results from Phase IIa Proof-of-Concept Study Supporting Therapeutic Potential of RHB-104 in Multiple Sclerosis
04/01/16
> Zytoprotec Appoints Joerg Vienken and Norbert Riedel to Supervisory Board
03/30/16
> Amal Therapeutics Raises CHF 3 Million in a Series A Financing Round Led by Boehringer Ingelheim Venture Fund
03/30/16
> ITM and Scil Proteins Announce New Partnership for Targeted Radio Conjugates
03/24/16
> Vetter Groundbreaking Ceremony Heralds the Creation of a New 70 Million Euro Production Building
03/22/16
> BioPharmaSpec Announces Expansion into Asia with New Business Development Teams
03/21/16
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Page 1 of 41